Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-03-28
2010-06-22
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07741489
ABSTRACT:
The present invention provides an improved synthetic strategy for the preparation of solifenacin and pharmaceutically acceptable salts thereof.
REFERENCES:
patent: 6017927 (2000-01-01), Takeuchi et al.
patent: 1714965 (2006-10-01), None
patent: 1757604 (2007-02-01), None
Naito et al., Journal of Medicinal Chemistry (2005), 48(21), 6597-6606.
U.S. Appl. No. 12/515,689, filed Aug. 4, 2009, Jordi Puig.
Naito et al., Synthesis and Antimuscarinic Properties of Quinuclidin-3-yl 1,2,3,4-Tetrahydroisoquinoline-2-carboxylate Derivatives as Novel Muscarinic Receptor Antagonists,J. Med. Chem.(2005) 48, 6597-6606.
Camps Pelayo
Puig Serrano Jordi
Cohen Pontani Lieberman & Pavane LLP
Medichem S.A.
Rahmani Niloofar
Seaman D. Margaret
LandOfFree
Process for the synthesis of solifenacin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process for the synthesis of solifenacin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the synthesis of solifenacin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4198996